Exchange: OTC·Updated 03:59 PM EDT
News
all
press releases
BioStem Technologies, Inc. (BSEM) Reports Q1 Loss, Tops Revenue Estimates
BioStem Technologies, Inc. (BSEM) delivered earnings and revenue surprises of -85.71% and +7.64%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Precigen, Inc. (PGEN) Reports Q1 Loss, Tops Revenue Estimates
Precigen (PGEN) delivered earnings and revenue surprises of +20.00% and +9.99%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Small and Micro-Cap Movers: Your Daily Digest of High-Impact News From High-Growth Companies Rising in Popularity
The only curated source of news from smaller, under-the-radar stocks in the hottest sectors ready to make a move, and the analysis and rumors from social media driving the price action.
Stocktwits Contributor
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments
Innovation is the lifeblood of the MedTech sector. Literally. Discoveries made are more than value drivers for the companies behind them; they can be life savers to millions needing better and more effective healthcare solutions.
Sponsored
<
1
>

Advertisement|Remove ads.